Prescription de médicaments génériques: impact du nouveau système de prix sur les coûts et les économies potentielles [Generic drug prescribing: pilot study on the impact of the new drug pricing system on costs and potential savings]

Details

Ressource 1Download: RMS_59_865.pdf (277.64 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_513FAA85F48E
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Prescription de médicaments génériques: impact du nouveau système de prix sur les coûts et les économies potentielles [Generic drug prescribing: pilot study on the impact of the new drug pricing system on costs and potential savings]
Journal
Revue medicale suisse
Author(s)
Wasserfallen J.B., Shimia S., Biollaz J., Pannatier A.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
29/03/2006
Peer-reviewed
Oui
Volume
2
Number
59
Pages
865-871
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
The impact of a systematic generic substitution and of the new drug pricing system (implemented in 2002 for cost saving reasons) on prescription cost was computed on the basis of prescriptions delivered in January 1999 for patients leaving our university hospital. A total of 3,099 prescriptions, representing 5,514 drugs, were delivered in one month, of which 335 (6%) were excluded (drug not available in 2002 or magistral preparations). Forced generic prescription would have saved 3,8% of global costs, while the new drug pricing system would have increased costs between 1,1% and 8,0%. In this specific setting, savings linked with forced generic drug prescription was weak (4 to 5%), and the expected savings of the new drug pricing system were not observed.
Keywords
Costs and Cost Analysis, Drugs, Generic/economics, Humans, Pilot Projects, Switzerland
Pubmed
Create date
25/01/2008 9:58
Last modification date
13/12/2024 9:12
Usage data